News Hikma rises on cancer generic deal with China’s Hansoh UK-listed Hikma Pharma has licensed an array of injectable cancer drugs from China’s Hansoh, sparking a rise in its share price.
UK & Europe Ex-Teva exec to be new Hikma CEO Hikma has a new chief executive after Said Darwazah, the son of the company’s late founder, Samih Darwazah, stepped aside.
News GSK gets short term boost as second US Advair generic reject... FDA rejects Hikma drug, regulator has "major" issue with Mylan's rival.
